Dysfunction of Myosin Light‐Chain 4 (MYL4) Leads to Heritable Atrial Cardiomyopathy With Electrical, Contractile, and Structural Components: Evidence From Genetically‐Engineered Rats
Wenhui Peng(Tongji University), Yawei Xu(Tongji University), Jingjing Xiao(BGI Group (China)), Stanley Nattel(Montreal Heart Institute), Dali Li(East China Normal University), Kai Tang, Jianguo Zhang(Beijing Institute of Genomics), Yongchun Yu(Weifang People's Hospital), Hailing Li(Tongji University), Jianhui Zhuang(Tongji University), Pak C. Sham(University of Hong Kong), Hui Jiang, Miaoxin Li(Sun Yat-sen University)
Cited by 80
Related Papers
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
The support of human genetic evidence for approved drug indications
|Nature Genetics|2015|1.8k
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
|New England Journal of Medicine|2008|1.6k
The Clinical Profile and Pathophysiology of Atrial Fibrillation
|Circulation Research|2014|1.2k